This research report provides a comprehensive analysis of the DNA Testing & Diagnostics market, focusing on the current trends, market dynamics, and future prospects. The report explores the global DNA Testing & Diagnostics market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of DNA Testing & Diagnostics, challenges faced by the industry, and potential opportunities for market players.
The global DNA Testing & Diagnostics market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The DNA Testing & Diagnostics market presents opportunities for various stakeholders, including Hospital, Medical Research. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in DNA Testing & Diagnostics market. Additionally, the growing consumer demand present avenues for market expansion.
The global DNA Testing & Diagnostics market was valued at US$ 10260 million in 2023 and is projected to reach US$ 23580 million by 2030, at a CAGR of 12.2% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the DNA Testing & Diagnostics market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the DNA Testing & Diagnostics market.
Market Overview: The report provides a comprehensive overview of the DNA Testing & Diagnostics market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., PCR-Based Diagnostics, ISH Diagnostics), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the DNA Testing & Diagnostics market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the DNA Testing & Diagnostics market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the DNA Testing & Diagnostics market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the DNA Testing & Diagnostics market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the DNA Testing & Diagnostics market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the DNA Testing & Diagnostics market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for DNA Testing & Diagnostics, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the DNA Testing & Diagnostics market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- DNA Testing & Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- PCR-Based Diagnostics
- ISH Diagnostics
- NGS DNA Diagnosis
Market segment by Application
- Hospital
- Medical Research
- Pharmacogenomics Diagnostic Testing
Global DNA Testing & Diagnostics Market Segment Percentages, By Region and Country, 2023 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Major players covered
- GE Healthcare
- 454 Life Sciences
- Abbott Laboratories
- Beckman Coulter
- Bio-Rad Laboratories
- Thermo Fisher Scientific
- Illumina
- Cephide
- Hologic
- Transgenomic
- Siemens Healthcare
- Roche Diagnostics
- Qiagen
- Affymetrix
- Agilent Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of DNA Testing & Diagnostics, market overview.
Chapter 2: Global DNA Testing & Diagnostics market size in revenue.
Chapter 3: Detailed analysis of DNA Testing & Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of DNA Testing & Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 DNA Testing & Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global DNA Testing & Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global DNA Testing & Diagnostics Overall Market Size
2.1 Global DNA Testing & Diagnostics Market Size: 2023 VS 2030
2.2 Global DNA Testing & Diagnostics Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top DNA Testing & Diagnostics Players in Global Market
3.2 Top Global DNA Testing & Diagnostics Companies Ranked by Revenue
3.3 Global DNA Testing & Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 DNA Testing & Diagnostics Companies in Global Market, by Revenue in 2023
3.5 Global Companies DNA Testing & Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 DNA Testing & Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 DNA Testing & Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 DNA Testing & Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global DNA Testing & Diagnostics Market Size Markets, 2023 & 2030
4.1.2 PCR-Based Diagnostics
4.1.3 ISH Diagnostics
4.1.4 NGS DNA Diagnosis
4.2 By Type - Global DNA Testing & Diagnostics Revenue & Forecasts
4.2.1 By Type - Global DNA Testing & Diagnostics Revenue, 2019-2024
4.2.2 By Type - Global DNA Testing & Diagnostics Revenue, 2025-2030
4.2.3 By Type - Global DNA Testing & Diagnostics Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global DNA Testing & Diagnostics Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Medical Research
5.1.4 Pharmacogenomics Diagnostic Testing
5.2 By Application - Global DNA Testing & Diagnostics Revenue & Forecasts
5.2.1 By Application - Global DNA Testing & Diagnostics Revenue, 2019-2024
5.2.2 By Application - Global DNA Testing & Diagnostics Revenue, 2025-2030
5.2.3 By Application - Global DNA Testing & Diagnostics Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global DNA Testing & Diagnostics Market Size, 2023 & 2030
6.2 By Region - Global DNA Testing & Diagnostics Revenue & Forecasts
6.2.1 By Region - Global DNA Testing & Diagnostics Revenue, 2019-2024
6.2.2 By Region - Global DNA Testing & Diagnostics Revenue, 2025-2030
6.2.3 By Region - Global DNA Testing & Diagnostics Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America DNA Testing & Diagnostics Revenue, 2019-2030
6.3.2 US DNA Testing & Diagnostics Market Size, 2019-2030
6.3.3 Canada DNA Testing & Diagnostics Market Size, 2019-2030
6.3.4 Mexico DNA Testing & Diagnostics Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe DNA Testing & Diagnostics Revenue, 2019-2030
6.4.2 Germany DNA Testing & Diagnostics Market Size, 2019-2030
6.4.3 France DNA Testing & Diagnostics Market Size, 2019-2030
6.4.4 U.K. DNA Testing & Diagnostics Market Size, 2019-2030
6.4.5 Italy DNA Testing & Diagnostics Market Size, 2019-2030
6.4.6 Russia DNA Testing & Diagnostics Market Size, 2019-2030
6.4.7 Nordic Countries DNA Testing & Diagnostics Market Size, 2019-2030
6.4.8 Benelux DNA Testing & Diagnostics Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia DNA Testing & Diagnostics Revenue, 2019-2030
6.5.2 China DNA Testing & Diagnostics Market Size, 2019-2030
6.5.3 Japan DNA Testing & Diagnostics Market Size, 2019-2030
6.5.4 South Korea DNA Testing & Diagnostics Market Size, 2019-2030
6.5.5 Southeast Asia DNA Testing & Diagnostics Market Size, 2019-2030
6.5.6 India DNA Testing & Diagnostics Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America DNA Testing & Diagnostics Revenue, 2019-2030
6.6.2 Brazil DNA Testing & Diagnostics Market Size, 2019-2030
6.6.3 Argentina DNA Testing & Diagnostics Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa DNA Testing & Diagnostics Revenue, 2019-2030
6.7.2 Turkey DNA Testing & Diagnostics Market Size, 2019-2030
6.7.3 Israel DNA Testing & Diagnostics Market Size, 2019-2030
6.7.4 Saudi Arabia DNA Testing & Diagnostics Market Size, 2019-2030
6.7.5 UAE DNA Testing & Diagnostics Market Size, 2019-2030
7 DNA Testing & Diagnostics Companies Profiles
7.1 GE Healthcare
7.1.1 GE Healthcare Company Summary
7.1.2 GE Healthcare Business Overview
7.1.3 GE Healthcare DNA Testing & Diagnostics Major Product Offerings
7.1.4 GE Healthcare DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.1.5 GE Healthcare Key News & Latest Developments
7.2 454 Life Sciences
7.2.1 454 Life Sciences Company Summary
7.2.2 454 Life Sciences Business Overview
7.2.3 454 Life Sciences DNA Testing & Diagnostics Major Product Offerings
7.2.4 454 Life Sciences DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.2.5 454 Life Sciences Key News & Latest Developments
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Company Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories DNA Testing & Diagnostics Major Product Offerings
7.3.4 Abbott Laboratories DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.3.5 Abbott Laboratories Key News & Latest Developments
7.4 Beckman Coulter
7.4.1 Beckman Coulter Company Summary
7.4.2 Beckman Coulter Business Overview
7.4.3 Beckman Coulter DNA Testing & Diagnostics Major Product Offerings
7.4.4 Beckman Coulter DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.4.5 Beckman Coulter Key News & Latest Developments
7.5 Bio-Rad Laboratories
7.5.1 Bio-Rad Laboratories Company Summary
7.5.2 Bio-Rad Laboratories Business Overview
7.5.3 Bio-Rad Laboratories DNA Testing & Diagnostics Major Product Offerings
7.5.4 Bio-Rad Laboratories DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.5.5 Bio-Rad Laboratories Key News & Latest Developments
7.6 Thermo Fisher Scientific
7.6.1 Thermo Fisher Scientific Company Summary
7.6.2 Thermo Fisher Scientific Business Overview
7.6.3 Thermo Fisher Scientific DNA Testing & Diagnostics Major Product Offerings
7.6.4 Thermo Fisher Scientific DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.6.5 Thermo Fisher Scientific Key News & Latest Developments
7.7 Illumina
7.7.1 Illumina Company Summary
7.7.2 Illumina Business Overview
7.7.3 Illumina DNA Testing & Diagnostics Major Product Offerings
7.7.4 Illumina DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.7.5 Illumina Key News & Latest Developments
7.8 Cephide
7.8.1 Cephide Company Summary
7.8.2 Cephide Business Overview
7.8.3 Cephide DNA Testing & Diagnostics Major Product Offerings
7.8.4 Cephide DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.8.5 Cephide Key News & Latest Developments
7.9 Hologic
7.9.1 Hologic Company Summary
7.9.2 Hologic Business Overview
7.9.3 Hologic DNA Testing & Diagnostics Major Product Offerings
7.9.4 Hologic DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.9.5 Hologic Key News & Latest Developments
7.10 Transgenomic
7.10.1 Transgenomic Company Summary
7.10.2 Transgenomic Business Overview
7.10.3 Transgenomic DNA Testing & Diagnostics Major Product Offerings
7.10.4 Transgenomic DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.10.5 Transgenomic Key News & Latest Developments
7.11 Siemens Healthcare
7.11.1 Siemens Healthcare Company Summary
7.11.2 Siemens Healthcare Business Overview
7.11.3 Siemens Healthcare DNA Testing & Diagnostics Major Product Offerings
7.11.4 Siemens Healthcare DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.11.5 Siemens Healthcare Key News & Latest Developments
7.12 Roche Diagnostics
7.12.1 Roche Diagnostics Company Summary
7.12.2 Roche Diagnostics Business Overview
7.12.3 Roche Diagnostics DNA Testing & Diagnostics Major Product Offerings
7.12.4 Roche Diagnostics DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.12.5 Roche Diagnostics Key News & Latest Developments
7.13 Qiagen
7.13.1 Qiagen Company Summary
7.13.2 Qiagen Business Overview
7.13.3 Qiagen DNA Testing & Diagnostics Major Product Offerings
7.13.4 Qiagen DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.13.5 Qiagen Key News & Latest Developments
7.14 Affymetrix
7.14.1 Affymetrix Company Summary
7.14.2 Affymetrix Business Overview
7.14.3 Affymetrix DNA Testing & Diagnostics Major Product Offerings
7.14.4 Affymetrix DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.14.5 Affymetrix Key News & Latest Developments
7.15 Agilent Technologies
7.15.1 Agilent Technologies Company Summary
7.15.2 Agilent Technologies Business Overview
7.15.3 Agilent Technologies DNA Testing & Diagnostics Major Product Offerings
7.15.4 Agilent Technologies DNA Testing & Diagnostics Revenue in Global Market (2019-2024)
7.15.5 Agilent Technologies Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. DNA Testing & Diagnostics Market Opportunities & Trends in Global Market
Table 2. DNA Testing & Diagnostics Market Drivers in Global Market
Table 3. DNA Testing & Diagnostics Market Restraints in Global Market
Table 4. Key Players of DNA Testing & Diagnostics in Global Market
Table 5. Top DNA Testing & Diagnostics Players in Global Market, Ranking by Revenue (2023)
Table 6. Global DNA Testing & Diagnostics Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global DNA Testing & Diagnostics Revenue Share by Companies, 2019-2024
Table 8. Global Companies DNA Testing & Diagnostics Product Type
Table 9. List of Global Tier 1 DNA Testing & Diagnostics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 DNA Testing & Diagnostics Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global DNA Testing & Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - DNA Testing & Diagnostics Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - DNA Testing & Diagnostics Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global DNA Testing & Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - DNA Testing & Diagnostics Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - DNA Testing & Diagnostics Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global DNA Testing & Diagnostics Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global DNA Testing & Diagnostics Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global DNA Testing & Diagnostics Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America DNA Testing & Diagnostics Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe DNA Testing & Diagnostics Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia DNA Testing & Diagnostics Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America DNA Testing & Diagnostics Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa DNA Testing & Diagnostics Revenue, (US$, Mn), 2025-2030
Table 30. GE Healthcare Company Summary
Table 31. GE Healthcare DNA Testing & Diagnostics Product Offerings
Table 32. GE Healthcare DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 33. GE Healthcare Key News & Latest Developments
Table 34. 454 Life Sciences Company Summary
Table 35. 454 Life Sciences DNA Testing & Diagnostics Product Offerings
Table 36. 454 Life Sciences DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 37. 454 Life Sciences Key News & Latest Developments
Table 38. Abbott Laboratories Company Summary
Table 39. Abbott Laboratories DNA Testing & Diagnostics Product Offerings
Table 40. Abbott Laboratories DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 41. Abbott Laboratories Key News & Latest Developments
Table 42. Beckman Coulter Company Summary
Table 43. Beckman Coulter DNA Testing & Diagnostics Product Offerings
Table 44. Beckman Coulter DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 45. Beckman Coulter Key News & Latest Developments
Table 46. Bio-Rad Laboratories Company Summary
Table 47. Bio-Rad Laboratories DNA Testing & Diagnostics Product Offerings
Table 48. Bio-Rad Laboratories DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 49. Bio-Rad Laboratories Key News & Latest Developments
Table 50. Thermo Fisher Scientific Company Summary
Table 51. Thermo Fisher Scientific DNA Testing & Diagnostics Product Offerings
Table 52. Thermo Fisher Scientific DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 53. Thermo Fisher Scientific Key News & Latest Developments
Table 54. Illumina Company Summary
Table 55. Illumina DNA Testing & Diagnostics Product Offerings
Table 56. Illumina DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 57. Illumina Key News & Latest Developments
Table 58. Cephide Company Summary
Table 59. Cephide DNA Testing & Diagnostics Product Offerings
Table 60. Cephide DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 61. Cephide Key News & Latest Developments
Table 62. Hologic Company Summary
Table 63. Hologic DNA Testing & Diagnostics Product Offerings
Table 64. Hologic DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 65. Hologic Key News & Latest Developments
Table 66. Transgenomic Company Summary
Table 67. Transgenomic DNA Testing & Diagnostics Product Offerings
Table 68. Transgenomic DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 69. Transgenomic Key News & Latest Developments
Table 70. Siemens Healthcare Company Summary
Table 71. Siemens Healthcare DNA Testing & Diagnostics Product Offerings
Table 72. Siemens Healthcare DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 73. Siemens Healthcare Key News & Latest Developments
Table 74. Roche Diagnostics Company Summary
Table 75. Roche Diagnostics DNA Testing & Diagnostics Product Offerings
Table 76. Roche Diagnostics DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 77. Roche Diagnostics Key News & Latest Developments
Table 78. Qiagen Company Summary
Table 79. Qiagen DNA Testing & Diagnostics Product Offerings
Table 80. Qiagen DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 81. Qiagen Key News & Latest Developments
Table 82. Affymetrix Company Summary
Table 83. Affymetrix DNA Testing & Diagnostics Product Offerings
Table 84. Affymetrix DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 85. Affymetrix Key News & Latest Developments
Table 86. Agilent Technologies Company Summary
Table 87. Agilent Technologies DNA Testing & Diagnostics Product Offerings
Table 88. Agilent Technologies DNA Testing & Diagnostics Revenue (US$, Mn) & (2019-2024)
Table 89. Agilent Technologies Key News & Latest Developments
List of Figures
Figure 1. DNA Testing & Diagnostics Segment by Type in 2023
Figure 2. DNA Testing & Diagnostics Segment by Application in 2023
Figure 3. Global DNA Testing & Diagnostics Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global DNA Testing & Diagnostics Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global DNA Testing & Diagnostics Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by DNA Testing & Diagnostics Revenue in 2023
Figure 8. By Type - Global DNA Testing & Diagnostics Revenue Market Share, 2019-2030
Figure 9. By Application - Global DNA Testing & Diagnostics Revenue Market Share, 2019-2030
Figure 10. By Type - Global DNA Testing & Diagnostics Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global DNA Testing & Diagnostics Revenue Market Share, 2019-2030
Figure 12. By Application - Global DNA Testing & Diagnostics Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global DNA Testing & Diagnostics Revenue Market Share, 2019-2030
Figure 14. By Region - Global DNA Testing & Diagnostics Revenue Market Share, 2019-2030
Figure 15. By Country - North America DNA Testing & Diagnostics Revenue Market Share, 2019-2030
Figure 16. US DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 17. Canada DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe DNA Testing & Diagnostics Revenue Market Share, 2019-2030
Figure 20. Germany DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 21. France DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 23. Italy DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 24. Russia DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia DNA Testing & Diagnostics Revenue Market Share, 2019-2030
Figure 28. China DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 29. Japan DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 32. India DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America DNA Testing & Diagnostics Revenue Market Share, 2019-2030
Figure 34. Brazil DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa DNA Testing & Diagnostics Revenue Market Share, 2019-2030
Figure 37. Turkey DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 38. Israel DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 40. UAE DNA Testing & Diagnostics Revenue, (US$, Mn), 2019-2030
Figure 41. GE Healthcare DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. 454 Life Sciences DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. Abbott Laboratories DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Beckman Coulter DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. Bio-Rad Laboratories DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Thermo Fisher Scientific DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. Illumina DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Cephide DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. Hologic DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Transgenomic DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Siemens Healthcare DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Roche Diagnostics DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. Qiagen DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 54. Affymetrix DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 55. Agilent Technologies DNA Testing & Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
